These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

247 related articles for article (PubMed ID: 26332141)

  • 1. Effect of Quadrivalent Human Papillomavirus Vaccination on Oral Squamous Cell Papillomas.
    Cyrus N; Blechman AB; Leboeuf M; Belyaeva EA; de Koning MN; Quint KD; Stern JJ
    JAMA Dermatol; 2015 Dec; 151(12):1359-1363. PubMed ID: 26332141
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Imiquimod versus podophyllotoxin, with and without human papillomavirus vaccine, for anogenital warts: the HIPvac factorial RCT.
    Gilson R; Nugent D; Bennett K; Doré CJ; Murray ML; Meadows J; Haddow LJ; Lacey C; Sandmann F; Jit M; Soldan K; Tetlow M; Caverly E; Nathan M; Copas AJ
    Health Technol Assess; 2020 Sep; 24(47):1-86. PubMed ID: 32975189
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Quadrivalent human papilloma virus vaccine for the treatment of multiple warts: a retrospective analysis of 30 patients.
    Yang MY; Son JH; Kim GW; Kim HS; Ko HC; Kim MB; Lim KM; Kim BS
    J Dermatolog Treat; 2019 Jun; 30(4):405-409. PubMed ID: 30232912
    [No Abstract]   [Full Text] [Related]  

  • 4. Tumor-specific and gender-specific pre-vaccination distribution of human papillomavirus types 6 and 11 in anogenital warts and laryngeal papillomas: a study on 574 tissue specimens.
    Komloš KF; Kocjan BJ; Košorok P; Luzar B; Meglič L; Potočnik M; Hočevar-Boltežar I; Gale N; Seme K; Poljak M
    J Med Virol; 2012 Aug; 84(8):1233-41. PubMed ID: 22711351
    [TBL] [Abstract][Full Text] [Related]  

  • 5. HPV Vaccination Status and Resolution of Warts in Pediatric Patients.
    Burli A; Hancock S; Zhao YT; Paul D; Cordisco M
    Indian J Dermatol; 2021; 66(6):604-608. PubMed ID: 35283520
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association of Human Papillomavirus Vaccine With the Development of Keratinocyte Carcinomas.
    Nichols AJ; Allen AH; Shareef S; Badiavas EV; Kirsner RS; Ioannides T
    JAMA Dermatol; 2017 Jun; 153(6):571-574. PubMed ID: 28196178
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Resolution of novel human papillomavirus-induced warts after HPV vaccination.
    Silling S; Wieland U; Werner M; Pfister H; Potthoff A; Kreuter A
    Emerg Infect Dis; 2014 Jan; 20(1):142-5. PubMed ID: 24378072
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Verruca vulgaris of the buccal mucosa: A case report.
    Mattoo A; Bhatia M
    J Cancer Res Ther; 2018; 14(2):454-456. PubMed ID: 29516939
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Quadrivalent human papillomavirus (types 6, 11, 16, 18) recombinant vaccine (Gardasil®): a review of its use in the prevention of premalignant genital lesions, genital cancer and genital warts in women.
    McCormack PL; Joura EA
    Drugs; 2010 Dec; 70(18):2449-74. PubMed ID: 21142263
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inclusion of the benefits of enhanced cross-protection against cervical cancer and prevention of genital warts in the cost-effectiveness analysis of human papillomavirus vaccination in the Netherlands.
    Westra TA; Stirbu-Wagner I; Dorsman S; Tutuhatunewa ED; de Vrij EL; Nijman HW; Daemen T; Wilschut JC; Postma MJ
    BMC Infect Dis; 2013 Feb; 13():75. PubMed ID: 23390964
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Quadrivalent Human Papillomavirus Vaccine: Recommendations of the Advisory Committee on Immunization Practices (ACIP).
    Markowitz LE; Dunne EF; Saraiya M; Lawson HW; Chesson H; Unger ER; ;
    MMWR Recomm Rep; 2007 Mar; 56(RR-2):1-24. PubMed ID: 17380109
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cross-protective efficacy of two human papillomavirus vaccines: a systematic review and meta-analysis.
    Malagón T; Drolet M; Boily MC; Franco EL; Jit M; Brisson J; Brisson M
    Lancet Infect Dis; 2012 Oct; 12(10):781-9. PubMed ID: 22920953
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Spotlight on quadrivalent human papillomavirus (types 6, 11, 16, 18) recombinant vaccine(Gardasil®) in the prevention of premalignant genital lesions, genital cancer, and genital warts in women.
    McCormack PL; Joura EA
    BioDrugs; 2011 Oct; 25(5):339-43. PubMed ID: 21942919
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gardasil Vaccination for Recurrent Laryngeal Papillomatosis in Adult Men Second Report: Negative Conversion of HPV in Laryngeal Secretions.
    Hirai R; Makiyama K; Matsuzaki H; Oshima T
    J Voice; 2018 Jul; 32(4):488-491. PubMed ID: 28866231
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of the quadrivalent HPV vaccine on disease recurrence in men exposed to HPV Infection: a randomized study.
    Coskuner ER; Ozkan TA; Karakose A; Dillioglugil O; Cevik I
    J Sex Med; 2014 Nov; 11(11):2785-91. PubMed ID: 25124237
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sustainability of neutralising antibodies induced by bivalent or quadrivalent HPV vaccines and correlation with efficacy: a combined follow-up analysis of data from two randomised, double-blind, multicentre, phase 3 trials.
    Mariz FC; Gray P; Bender N; Eriksson T; Kann H; Apter D; Paavonen J; Pajunen E; Prager KM; Sehr P; Surcel HM; Waterboer T; Müller M; Pawlita M; Lehtinen M
    Lancet Infect Dis; 2021 Oct; 21(10):1458-1468. PubMed ID: 34081923
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cost-effectiveness of different human papillomavirus vaccines in Singapore.
    Lee VJ; Tay SK; Teoh YL; Tok MY
    BMC Public Health; 2011 Mar; 11():203. PubMed ID: 21453537
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oral and oropharyngeal papillomas are not associated with high-risk human papillomavirus infection.
    Snietura M; Lamch R; Kopec A; Waniczek D; Likus W; Lange D; Markowski J
    Eur Arch Otorhinolaryngol; 2017 Sep; 274(9):3477-3483. PubMed ID: 28639061
    [TBL] [Abstract][Full Text] [Related]  

  • 19. HPV-Related Papillary Lesions of the Oral Mucosa: A Review.
    Betz SJ
    Head Neck Pathol; 2019 Mar; 13(1):80-90. PubMed ID: 30693456
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clearance of recalcitrant warts in a pediatric patient following administration of the nine-valent human papillomavirus vaccine.
    Kost Y; Zhu TH; Blasiak RC
    Pediatr Dermatol; 2020 Jul; 37(4):748-749. PubMed ID: 32173894
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.